Correlation Between ESSA Pharma and Icad
Can any of the company-specific risk be diversified away by investing in both ESSA Pharma and Icad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ESSA Pharma and Icad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ESSA Pharma and icad inc, you can compare the effects of market volatilities on ESSA Pharma and Icad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ESSA Pharma with a short position of Icad. Check out your portfolio center. Please also check ongoing floating volatility patterns of ESSA Pharma and Icad.
Diversification Opportunities for ESSA Pharma and Icad
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ESSA and Icad is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding ESSA Pharma and icad inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on icad inc and ESSA Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ESSA Pharma are associated (or correlated) with Icad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of icad inc has no effect on the direction of ESSA Pharma i.e., ESSA Pharma and Icad go up and down completely randomly.
Pair Corralation between ESSA Pharma and Icad
Given the investment horizon of 90 days ESSA Pharma is expected to under-perform the Icad. In addition to that, ESSA Pharma is 1.7 times more volatile than icad inc. It trades about -0.12 of its total potential returns per unit of risk. icad inc is currently generating about 0.09 per unit of volatility. If you would invest 152.00 in icad inc on September 12, 2024 and sell it today you would earn a total of 37.00 from holding icad inc or generate 24.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
ESSA Pharma vs. icad inc
Performance |
Timeline |
ESSA Pharma |
icad inc |
ESSA Pharma and Icad Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ESSA Pharma and Icad
The main advantage of trading using opposite ESSA Pharma and Icad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ESSA Pharma position performs unexpectedly, Icad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icad will offset losses from the drop in Icad's long position.ESSA Pharma vs. Equillium | ESSA Pharma vs. DiaMedica Therapeutics | ESSA Pharma vs. Valneva SE ADR | ESSA Pharma vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |